Skip to content

Clinical trials

Active, not recruiting Phase 1/2 Brain Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 1/2 Status: Active, not recruiting Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20171
20191
20203
20222
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
InSightec2
AstraZeneca1
Black Diamond Therapeutics, Inc.1
Colette Shen1
In8bio Inc.1
M.D. Anderson Cancer Center1
Sapience Therapeutics1
TME Pharma AG1
University of Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms13
Breast Neoplasms3
Glioblastoma3
Glioma3
Carcinoma, Non-Small-Cell Lung2
Central Nervous System Neoplasms2
Lung Neoplasms1
Medulloblastoma1
Melanoma1
Neoplasm Metastasis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.